Maintenance of totally implantable central venous catheter access port (port-a-cath) in oncology: integrating literature review

×

Error message

User warning: The following theme is missing from the file system: journalijdr. For information about how to fix this, see the documentation page. in _drupal_trigger_error_with_delayed_logging() (line 1138 of /home2/journalijdr/public_html/includes/bootstrap.inc).

International Journal of Development Research

Volume: 
8
Article ID: 
14293
6 pages
Research Article

Maintenance of totally implantable central venous catheter access port (port-a-cath) in oncology: integrating literature review

Débora Cristina da Silva Farias, Zélia de Oliveira Saldanha, João Victor Moura Garcia, Marta Solange Camarinha Ramos Costa, Samuel Oliveira Da Vera, Maicon de Araújo Nogueira and Aline Maria Pereira Cruz Ramos

Abstract: 

Introduction: The totally implantable central venous catheter access port (TICVAP), known as Port-a-cath, is the most suitable access to prolonged antineoplastic chemotherapy, whose handling and prevention of catheter occlusion are under the responsibility of the nurse. Objective: To analyze the available evidence on the maintenance TICVAP in oncology in the literature. Methodology: Integrative literature review with selection of works indexed in the databases: SciELO, Pubmed and ScienceDirect, using the keywords "Flushing and locking", "Totally Implantable Central Venous Catheters", "Oncology Patients" and "Protocols ". The research was carried out between January 2017 and August 2018, with publications from 2007-2018, 58 publications were selected relevant for the development of the study through the analysis of the abstracts and later with the evaluation of the texts in totally were selected 23 publications. Results: The use of 0.9% sodium chloride, ethanol, antimicrobials or heparin concentrate was identified for flushing and locking, but without standardization of the best solution to be used. Conclusion: There are few studies on the subject, without significant scientific evidence to support a standardization regarding the maintenance of TICVAP blockade, and it is necessary to carry out new researches with cancer patients to support the clinical practice based on evidence.

Download PDF: